Food and Drug Administration (FDA) for Ralivia(TM) FlashDose(R), an orally disintegrating tablet version of the analgesic medication tramadol hydrochloride, intended for the treatment of moderate to moderately severe pain. Business Editors/Health/Medical Writers TORONTO--(BUSINESS WIRE)--March 11, 2004 Biovail Corporation (NYSE:BVF) (TSX:BVF) announced today that it has submitted a New Drug Application to the U. Accordingly, it would be an excellent complement to our once-daily tramadol product for the treatment of persistent pain.
" Currently marketed tramadol-acetaminophen combination prescription for tramadol products must be administered four- to six-times per day.
Although prescription for tramadol we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Additional company information is available on the Internet Prescription for tramadol at www. Dadebehring. Sales for the existing immediate-release version of Tramadol for the year ending July 2000 were in excess of $475 million. Lehigh Valley Technologies is a cGMP pharmaceutical company Prescription for tramadol focusing on two specific areas: the decongestant market and pain management. Lehigh Valley Prescription for tramadol technologies Inc. We anticipate announcing results of the trial sometime in the third quarter Prescription for tramadol of 2001. This trial follows an earlier Phase II clinical trial of PTI-601, which was designed to evaluate safety prescription for tramadol and efficacy in patients with moderate to severe pain. Howard, president and chief executive officer of Nutraceutix, stated, We are pleased to be working with Lehigh Valley Technologies once again.
Eugene Melnyk, Chairman of the Board and Chief Executive Officer commented, The filing of Ralivia FlashDose is very significant, complementing our filing of Ralivia ER and marking our development prescription for tramadol of a franchise of pain medications. Howard-Tripp, President and Chief Executive prescription for tramadol officer, Labopharm Inc. She had pleaded guilty as part of a plea bargain to aggravated identity theft, conspiracy, health care fraud and making false claims to the United States. For additional information, please visit the Company's Web site at www. Paintrials. FDA also has sent a letter to health-care professionals on the drug's safety. Since Ultram was approved March 3, 1995, FDA has received 115 reports of drug abuse, dependence, withdrawal symptoms, and intentional overdose by people taking the drug. Labopharm believes that by metering the release of both tramadol and acetaminophen from a single tablet using its Contramid(R) controlled-release technology, its formulation has the potential to offer enhanced patient compliance through twice-daily administration, as well as a potentially improved side effect profile. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. He pleaded to conspiracy, two counts of health care fraud and making prescription for tramadol false claims to the U.